Validations: Chain-of-Identity/Chain-of-Custody
Case Library: COI/COC Issues and Resolutions Case Library: COI/COC Issues and Resolutions Introduction to Chain-of-Identity and Chain-of-Custody in Biologics In the context of biopharmaceuticals, ensuring the integrity and traceability of products is paramount. This article serves as a comprehensive guide addressing Chain-of-Identity (COI) and Chain-of-Custody (COC) issues encountered during the manufacturing processes of Advanced Therapy Medicinal Products (ATMPs) and biologics….
COI/COC Governance for Multi-Site Programs COI/COC Governance for Multi-Site Programs Introduction to COI/COC in Biologics and Advanced Therapy Medicinal Products (ATMP) The governance of Chain-of-Identity (COI) and Chain-of-Custody (COC) is paramount in the field of biologics and ATMP validation. These processes ensure the proper tracking and safeguarding of biological materials throughout their lifecycle, from collection to patient administration. As global…
3rd-Party Platforms for COI/COC: Due Diligence 3rd-Party Platforms for COI/COC: Ensuring Due Diligence in Biologics and ATMP Validation Introduction to Chain-of-Identity and Chain-of-Custody in Biologics As the demand for biologics and advanced therapy medicinal products (ATMPs) rises, the need for rigorous validation processes within the pharmaceutical landscape becomes increasingly critical. Chain-of-Identity (COI) and Chain-of-Custody (COC) are essential frameworks that safeguard…
Lifecycle of COI/COC Records: Retention & Retrieval The lifecycle management of Chain-of-Identity (COI) and Chain-of-Custody (COC) records is critical in the pharmaceutical industry, particularly in the development and validation of biologics and Advanced Therapy Medicinal Products (ATMPs). A robust understanding of regulatory requirements, best practices for retention, and retrieval processes is essential for professionals engaged in quality assurance, regulatory affairs,…
Mock Recalls/Simulations Focused on COI/COC Mock Recalls/Simulations Focused on Chain-of-Identity and Chain-of-Custody In the highly regulated field of biologics and advanced therapy medicinal products (ATMPs), ensuring the integrity of the chain-of-identity (COI) and chain-of-custody (COC) is paramount. This article presents a step-by-step guide aimed at pharmaceutical professionals involved in validation processes, focusing on mock recalls and simulations specifically tailored for…
Training for COI/COC: Roles and Competency Understanding Chain-of-Identity and Chain-of-Custody in Biologics Chain-of-Identity (COI) and Chain-of-Custody (COC) are critical components in biologics manufacturing, particularly for Advanced Therapy Medicinal Products (ATMPs). These concepts ensure traceability, accountability, and safety throughout the lifecycle of a product. Effective training in COI and COC principles equips pharmaceutical professionals with the necessary knowledge to manage and…
COI/COC Deviations: CAPA and Effectiveness COI/COC Deviations: CAPA and Effectiveness This tutorial provides a comprehensive step-by-step guide for pharmaceutical professionals focused on Chain-of-Identity (COI) and Chain-of-Custody (COC) deviations, highlighting the importance of Corrective and Preventive Actions (CAPA) and effectiveness in the context of viral clearance validation, particularly in biologics, Advanced Therapy Medicinal Products (ATMP), and their associated complex critical quality…
COI/COC in Closed vs Open Steps: A Comprehensive Guide for Pharmaceutical Validation In the realm of pharmaceutical and biologics development, maintaining stringent quality assurance protocols is paramount. This holds especially true for Chain-of-Identity (COI) and Chain-of-Custody (COC) during all stages of production, particularly in closed versus open systems. This article serves as a detailed guide to navigating these critical validation…
COI/COC Documentation Architecture Introduction to Chain-of-Identity and Chain-of-Custody Documentation The pharmaceutical industry, especially in the context of biologics and advanced therapy medicinal products (ATMPs), requires strict adherence to regulatory guidelines governing cold chain management, viral clearance validation, and potential contamination controls. The Chain of Identity (COI) and Chain of Custody (COC) are integral concepts that ensure the traceability and safety…
Risk Assessments for COI/COC Breaks Risk Assessments for COI/COC Breaks: A Comprehensive Guide In the realm of biologics and advanced therapy medicinal products (ATMP), the integrity of chain-of-identity (COI) and chain-of-custody (COC) is paramount. Compliance with regulatory expectations necessitates a robust approach to risk assessment, especially concerning viral clearance and control measures. This guide demystifies the multifaceted process of conducting…